Future Transfer is preparing to establish a significant new presence in London, Ontario, with more than 400,000 sq. ft. of potential capacity available to support customer growth.
The site represents another important investment in our expanding Canadian network and creates new opportunities to support manufacturing, warehousing, rail transloading and integrated supply chain programs from a strategically located Southwestern Ontario market.
Flexible Capacity Built Around Customer Needs
The London location is being positioned with flexibility in mind.
Depending on customer requirements, the space can support manufacturing operations, large-scale warehousing, rail transloading or a combination of services within one coordinated solution.
This approach reflects how Future Transfer continues to grow: by developing infrastructure that can be tailored around the specific operational and supply chain requirements of our customers.
Strengthening Our Ontario Network
London provides an important location within Southwestern Ontario, supporting access to major manufacturing, agricultural and distribution markets.
Expanding capacity in the region strengthens Future Transfer's ability to support customers that require additional space, new production capabilities or a more efficient supply chain footprint.
Investing in What's Next
As Future Transfer continues to grow, our focus remains on building the facilities, equipment and capabilities our customers need to move forward.
The London expansion is another step in developing a stronger national platform that brings manufacturing, warehousing, transloading and logistics together under one experienced supply chain partner.

Beyond Warehousing: In-House Millwright Capabilities Support Complex Facility Transitions
When a customer needs to transition operations from one facility to another, the challenge extends far beyond transportation.
Read Article
Future Transfer Reaches New Manufacturing Milestone with Full-Scale SC Production
Future Transfer has reached an important manufacturing milestone with the successful completion of its first full-scale Suspension Concentrate (SC) batch, produced in collaboration with Bayer.
Read Article
